Regulation 29 Amendment of regulation 38 (imports)I1
United Kingdom
Regulation 38 M1 is amended as follows.
In the heading, after “states other than EEA states” insert “/ countries other than approved countries for import”.
In paragraph (2) for “from a state other than an EEA State” substitute—
“from—
(a)in the case of an import into Great Britain, a country other than an approved country for import, or
(b)in the case of an import into Northern Ireland, a country other than an EEA State”.
In paragraph (3)(b) for “a state other than an EEA State” substitute “, in the case of an import into Great Britain, a country other than an approved country for import and in the case of an import into Northern Ireland, a country other than an EEA State”.
Annotations
Textual amendments
- F1
Reg. 29(2) substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 19(a)
- F2
Reg. 29(3) substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 19(b)
- F3
Reg. 29(4) inserted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 19(c)
Marginal citations
- M1
Regulation 38 was amended by S.I. 2015/1503.
Commencement
- I1
Reg. 29 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1